On Retinal Gene Therapy.
Mutations in a large number of genes cause retinal degeneration and blindness with no cure currently available. Retinal gene therapy has evolved over the last decades to become a promising new treatment paradigm for these rare disorders. This article reflects on the ideas and concepts arising from basic science towards the translation of retinal gene therapy into the clinical realm. It describes the advances and present thinking on the efficacy of current clinical trials and discusses potential roadblocks and solutions for the future of retinal gene therapy.
University Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
M Dominik
MD
Fischer
D004247:DNA / Q000235:genetics; D004252:DNA Mutational Analysis; D005136:Eye Proteins / Q000235:genetics / Q000378:metabolism; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D009154:Mutation; D012160:Retina / Q000473:pathology*; D012162:Retinal Degeneration / Q000175:diagnosis / Q000235:genetics / Q000628:therapy
D005136:Eye Proteins; C099929:RPGR protein, human; D004247:DNA